Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2021-09-20 Report Publication Anno…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Annual Financial Report
Report Publication Announcement Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 3235M' and the footer mentioning RNS) dated September 20, 2021. The core purpose of this announcement is to state that the 'Annual Report and Accounts for the year ended 30 June 2021, Notice of Annual General Meeting and Proxy Form have now been mailed to shareholders' and that copies have been submitted to the FCA viewing facility. Since the document is short and its primary function is to announce the publication/mailing of the Annual Report and AGM materials rather than being the full report itself, it fits the definition of a Report Publication Announcement (RPA). Although it mentions the Annual Report (10-K) and AGM materials (AGM-R), the filing itself is the announcement of their availability.
2021-09-20 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification disseminated via RNS (RNS Number : 1755M) dated September 17, 2021. The content explicitly details 'Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs)' concerning the granting of Long Term Incentive Plan (LTIP) awards to Directors (Ian Page, Paul Sandland, Tony Griffin). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it uses the EU Market Abuse Regulation format, the core subject matter is insider trading/dealing disclosure.
2021-09-17 English
Block listing Interim Review
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled 'BLOCK LISTING SIX MONTHLY RETURN' and is issued via 'RNS Number : 8549L' on 15 September 2021. It details the status of unallotted securities under various share option schemes over a six-month period (March 15, 2021, to September 14, 2021). This type of periodic filing concerning share schemes and regulatory reporting via RNS (Regulatory News Service) does not fit neatly into the specific financial report categories (like 10-K, IR, ER) or corporate action categories (like DIV, SHA). Since it is a formal regulatory announcement provided through the London Stock Exchange's news service (RNS), and it doesn't match any other specific category, the most appropriate classification is the general regulatory filing fallback category.
2021-09-15 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of Transactions by Person Discharging Managerial Responsibilities' and details the sale of shares by an Executive Director (Tony Griffin). It explicitly states that the notification is provided in accordance with the UK Market Abuse Regulation and includes a detailed 'Notification of Dealing Form'. This content directly corresponds to the definition of Director's Dealing (insider trades). The RNS Number and the mention of the London Stock Exchange confirm it is a regulatory disclosure. Therefore, the appropriate code is DIRS.
2021-09-13 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is a formal notification titled 'Notification of Transactions by Person Discharging Managerial Responsibilities' concerning a purchase of shares by a Non-Executive Director (Denise Goode). It explicitly mentions compliance with the 'UK Market Abuse Regulation' and includes a detailed 'Notification of Dealing Form'. This type of insider transaction disclosure by a director is specifically categorized as Director's Dealing (DIRS). Although it is distributed via RNS, the content is highly specific to insider trading disclosure, making DIRS the most accurate classification over the general RNS fallback.
2021-09-09 English
Dechra Pharmaceuticals PLC - 2021 Annual Report
Annual Report Classification · 100% confidence The document is explicitly titled 'Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2021'. It contains comprehensive sections including a strategic report, governance information, financial statements, and auditor's reports, which are characteristic of a full annual report. It is not a short announcement or a certification, thus it fits the definition of a 10-K (Annual Report). FY 2021
2021-09-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.